Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| ARTIVION, INC. | 230,794 | reported | 03 Mar 2026 | tx 161+616,847−293,246 |
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 03 Mar 2026 | SALE | ARTIVION, INC. | 4,573 | 37.78 USD | |
| 02 Mar 2026 | GRANT_AWARD | ARTIVION, INC. | 28,845 | 0.00 USD | |
| 02 Mar 2026 | SALE | ARTIVION, INC. | 2,784 | 38.02 USD | |
| 24 Feb 2026 | SALE | ARTIVION, INC. | 2,075 | 35.69 USD | |
| 24 Feb 2026 | GRANT_AWARD | ARTIVION, INC. | 20,438 | 0.00 USD | |
| 23 Feb 2026 | SALE | ARTIVION, INC. | 3,773 | 37.59 USD | |
| 30 Jun 2025 | GRANT_AWARD | ARTIVION, INC. | 874 | 24.30 USD | |
| 15 Dec 2025 | SALE | ARTIVION, INC. | 5,000 | 45.11 USD | |
| 17 Nov 2025 | SALE | ARTIVION, INC. | 6,394 | 45.17 USD | |
| 17 Nov 2025 | EXERCISE | ARTIVION, INC. | 6,394 | 29.62 USD | |
| 14 Nov 2025 | SALE | ARTIVION, INC. | 6,393 | 44.67 USD | |
| 14 Nov 2025 | EXERCISE | ARTIVION, INC. | 6,393 | 29.62 USD | |
| 17 Nov 2025 | EXERCISE | ARTIVION, INC. | 6,394 | 0.00 USD | deriv |
| 14 Nov 2025 | EXERCISE | ARTIVION, INC. | 6,393 | 0.00 USD | deriv |
| 13 Nov 2025 | SALE | ARTIVION, INC. | 6,563 | 45.86 USD | |
| 10 Nov 2025 | SALE | ARTIVION, INC. | 3,373 | 44.62 USD | |
| 12 Aug 2025 | SALE | ARTIVION, INC. | 10,802 | 43.67 USD | |
| 12 Aug 2025 | EXERCISE | ARTIVION, INC. | 10,802 | 26.24 USD | |
| 12 Aug 2025 | EXERCISE | ARTIVION, INC. | 10,802 | 0.00 USD | deriv |
| 11 Mar 2025 | SALE | ARTIVION, INC. | 15,100 | 23.61 USD | |
| 11 Mar 2025 | EXERCISE | ARTIVION, INC. | 15,910 | 21.55 USD | |
| 11 Mar 2025 | EXERCISE | ARTIVION, INC. | 15,910 | 0.00 USD | deriv |
| 06 Mar 2025 | SALE | ARTIVION, INC. | 2,618 | 24.80 USD | |
| 06 Mar 2025 | GRANT_AWARD | ARTIVION, INC. | 25,654 | 0.00 USD | |
| 28 Feb 2025 | GRANT_AWARD | ARTIVION, INC. | 24,301 | 0.00 USD |
1 purchase reported after at least 12 months of silence — most recent on 29 Nov 2021.